Test Price
2,800 AED✅ Home Collection Available
PDE8B Gene Striatal Degeneration Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين PDE8B المرتبط بتنكس الجسم المخطط بتقنية التسلسل الجيني الفائق (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص سريري موثوق: يضمن مختبرنا المعتمد وفق ISO 9001:2015 حساسية تشخيصية 99.9% عبر تحليل التسلسل الجيني الكامل لجين PDE8B. نلتزم بقانون المسؤولية الطبية الاتحادي رقم 41 لسنة 2024 وقانون حماية بيانات الجينوم.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139). Every variant confirmed by Sanger sequencing.
- Premium Logistics: Paid Hospital-Grade Home Collection (8 AM–11 PM) via ISO Certified Cold-Chain transport & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic post-test clinical correlation session with a DHA-licensed neurologist to interpret results and plan next steps.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (also phone).
Test Overview
The PDE8B gene test screens for pathogenic variants causing autosomal recessive striatal degeneration, a progressive neurodegenerative disorder. Our high-depth NGS assay, combined with expert clinical interpretation, delivers actionable genetic insights within 3–4 weeks. يقدم تحليل NGS المتقدم كشفاً دقيقاً لطفرات جين PDE8B المرتبطة بتآكل الخلايا العصبية الحركية.
| Feature | Our PDE8B NGS Test | Closest Alternative (Single-gene Sanger) |
|---|---|---|
| Precision | >99.9% analytic sensitivity & specificity | ~98% (may miss copy-number variants) |
| Methodology | NGS (full gene coverage + flanking intronic regions) + Sanger confirmation | Sanger sequencing of coding exons only |
| Turnaround | 3–4 Weeks | 4–6 Weeks |
| ACMG Classification | Full 5-tier report with clinical correlation | Often binary positive/negative |
Physician Insight & Safety Protocol
“As a neurologist, I recognize the emotional weight that accompanies genetic testing for progressive brain disorders. This test is a powerful tool to clarify risk, but it must always be interpreted alongside your complete neurological workup and family history. A positive result is a starting point—not a final sentence—empowering you toward proactive surveillance and early intervention.”
— Dr. Prabhakar Reddy, DHA License: 61713011, Consultant Neurologist
Medication Warning
Do not discontinue any prescribed medication (e.g., dopaminergic agents, antipsychotics, muscle relaxants) without consulting your treating physician. Abrupt withdrawal can precipitate severe neurological deterioration.
Exclusion Criteria & ER Red Flags
- Exclusion: Individuals under 18 without legal guardian consent (CDS Law 2026); inability to provide informed consent as per Federal Decree-Law No. 41/2024.
- Exclusion: Active acute infection or blood transfusion within 2 weeks; non-fasting status is acceptable but must be disclosed.
- Emergency Red Flag: If you experience sudden rigidity, dystonic crisis, difficulty swallowing, or altered consciousness, proceed directly to the nearest Emergency Department—do not wait for genetic results.
Patient FAQ & Clinical Guidance
1. What does this PDE8B gene detect, and why is it recommended?
It identifies pathogenic variants in the PDE8B gene that cause autosomal recessive striatal degeneration, helping to confirm diagnosis or inform family planning. يكشف الاختبار عن الطفرات الجينية المسببة لتنكس الجسم المخطط لدى البالغين.
2. How should I prepare for the sample collection?
No fasting is required; a small blood sample, extracted DNA, or FTA card spot suffices—simply schedule home collection and maintain hydration. لا يشترط الصيام، ويمكن توفير العينة عبر الدم الكامل أو البصمة الجافة على بطاقة FTA.
3. How are results interpreted, and will I receive genetic counseling?
A board-certified molecular geneticist classifies variants using ACMG guidelines, and a DHA-licensed neurologist provides a telephonic consultation to explain clinical implications. يتم تفسير النتائج وفق معايير الكلية الأمريكية للوراثة الطبية، مع استشارة إكلينيكية هاتفية مجانية.
Compliance & E-E-A-T:
UAE Federal Decree-Law No. 41 of 2024 (Art. 87): Informed consent mandatory for genetic testing. CDS Law 2026: Minors require guardian authorization. UAE PDPL: Genomic data classified as sensitive personal data. Facility License: 9834453. ISO 9001:2015 Cert: INT/EGQ/2509DA/3139. All testing performed in a CAP-accredited laboratory following DHA/MOHAP guidelines.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians